Compare ECX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECX | SOPH |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United Kingdom | Switzerland |
| Employees | 1432 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.7M | 374.1M |
| IPO Year | N/A | 2021 |
| Metric | ECX | SOPH |
|---|---|---|
| Price | $1.17 | $5.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | ★ 2.0M | 236.0K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $819.14 | $23.09 |
| Revenue Next Year | $32.36 | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $2.83 |
| 52 Week High | $2.70 | $5.71 |
| Indicator | ECX | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 66.47 |
| Support Level | $1.05 | $4.59 |
| Resistance Level | $1.28 | N/A |
| Average True Range (ATR) | 0.11 | 0.36 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 51.35 | 87.17 |
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the Peoples Republic of China. The companies core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.